Publications dans lesquelles il/elle collabore avec Esther Jiménez (11)

2024

  1. Processing speed mediates the relationship between DDR1 and psychosocial functioning in euthymic patients with bipolar disorder presenting psychotic symptoms

    Molecular Psychiatry, Vol. 29, Núm. 7, pp. 2050-2058

2023

  1. Exploration of cannabis use and polygenic risk scores on the psychotic symptom progression of a FEP cohort

    Psychiatry Research, Vol. 325

2021

  1. Spanish validation of the Empirically Developed Clinical Staging Model (EmDe-5) for patients with bipolar disorder

    Revista de Psiquiatria y Salud Mental

  2. Trajectories of suicidal ideation after first-episode psychosis: a growth mixture modeling approach

    Acta psychiatrica Scandinavica, Vol. 143, Núm. 5, pp. 418-433

2020

  1. Personalized medicine begins with the phenotype: identifying antipsychotic response phenotypes in a first-episode psychosis cohort

    Acta Psychiatrica Scandinavica, Vol. 141, Núm. 6, pp. 541-552

2018

  1. Factors associated with poor functional outcome in bipolar disorder: sociodemographic, clinical, and neurocognitive variables

    Acta Psychiatrica Scandinavica, Vol. 138, Núm. 2, pp. 145-154

2017

  1. Do patients with bipolar disorder and subsyndromal symptoms benefit from functional remediation? A 12-month follow-up study

    European Neuropsychopharmacology, Vol. 27, Núm. 4, pp. 350-359

2016

  1. Cognitive reserve in bipolar disorder: Relation to cognition, psychosocial functioning and quality of life

    Acta Psychiatrica Scandinavica, Vol. 133, Núm. 5, pp. 386-398

  2. Effects of functional remediation on neurocognitively impaired bipolar patients: Enhancement of verbal memory

    Psychological Medicine, Vol. 46, Núm. 2, pp. 291-301

  3. Functional remediation in bipolar disorder: 1-year follow-up of neurocognitive and functional outcome

    British Journal of Psychiatry, Vol. 208, Núm. 1, pp. 87-93

2015

  1. Functional remediation for patients with bipolar II disorder: Improvement of functioning and subsyndromal symptoms

    European Neuropsychopharmacology, Vol. 25, Núm. 2, pp. 257-264